Aerovate Therapeutics Inc...
(AVTE)
undefined
undefined%
At close: undefined
2.70
0.19%
After-hours Jan 06, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -75.52M | -51.51M | -22.96M | -9.61M | -3.33M |
| Depreciation & Amortization | 96.00K | 68.00K | 15.00K | 1K | n/a |
| Stock-Based Compensation | 11.91M | 5.48M | 2.04M | 58.00K | n/a |
| Other Working Capital | 9.96M | 6.39M | -7.12M | 937.00K | 113.00K |
| Other Non-Cash Items | -3.06M | -910.00K | 16.00K | 719.00K | -436.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 9.80M | 7.75M | -6.51M | 974.00K | 549.00K |
| Operating Cash Flow | -56.78M | -39.12M | -27.40M | -7.86M | -2.78M |
| Capital Expenditures | -142.00K | -195.00K | -181.00K | n/a | n/a |
| Acquisitions | n/a | -7.12K | n/a | n/a | n/a |
| Purchase of Investments | -123.98M | -147.62M | -113.25M | n/a | n/a |
| Sales Maturities Of Investments | 136.00M | 154.74M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 7.12K | -113.25K | n/a | n/a |
| Investing Cash Flow | 11.88M | 6.93M | -113.43M | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 2.50M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.22M | 396.00K | 63.51M | 12.83M | 2.50M |
| Financial Cash Flow | 46.00M | 396.00K | 190.46M | 8.92M | 2.50M |
| Net Cash Flow | 1.09M | -31.80M | 49.62M | 1.06M | -281.00K |
| Free Cash Flow | -56.92M | -39.32M | -27.58M | -7.86M | -2.78M |